Omnitrope is a brand-name injectable solution prescribed for growth hormone deficiency in adults and children. It contains the active ingredient somatropin. Omnitrope may not be safe to receive during ...

Recently, amid controversy over the appropriateness of the growth hormone injection through broadcasting, the authorities have issued a warning of abuse. The Ministry of Food and Drug Safety said it ...

Five people appear to have developed Alzheimer’s disease after receiving growth hormones from deceased donors’ brains as children. Although based on a small group of people, this suggests that the ...

Researchers say they have uncovered more evidence to support a controversial hypothesis that sticky proteins that are a signature of Alzheimer’s disease can be transmitted from person to person ...

Dr. Jennifer Miller has been an author of dozens of studies about rare endocrine diseases over the last two decades. Hundreds of patients fly to Gainesville, Fla., from all over the U.S. to see her ...

Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...

NEW YORK & MIAMI--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) has approved NGENLA (somatrogon-ghla), a ...

New, longer-acting treatment offers option to reduce the frequency of injections for children with growth hormone deficiency from daily to once-weekly Growth hormone deficiency (GHD) is a rare disease ...